Table 1. Clinical and laboratory features of patients with gouty arthritis and rheumatoid arthritis.
Gouty arthritis | Rheumatoid arthritis | Controls | |||||||
n | % | Mean±SD | n | % | Mean±SD | n | % | Mean±SD | |
Sex | |||||||||
Male | 96 | 40 | 34 | ||||||
Female | 26 | 42 | 27 | ||||||
Age (years) | 64.6±13.4 | 62.1±12.9 | 65.3±4.8 | ||||||
Diabetes mellitus | 15 | 12,3 | 12 | 14,6 | |||||
Hypertension | 70 | 57,4 | 23 | 28 | |||||
Hyperlipidemia | 20 | 16,4 | 9 | 11 | |||||
Smoking | 33 | 27 | 19 | 23,2 | |||||
Alcohol | 30 | 24,6 | 3 | 3,7 | |||||
Ischemic heart disease | 18 | 14,8 | 11 | 13,4 | |||||
Cerebrovascular disease | 6 | 4,9 | 3 | 3,7 | |||||
ESR (mm/hr) | 57.0±29.8 | 58±27.1 | 14.0±9.2 | ||||||
CRP (mg/dL) | 9.5±19.3 | 4.7±5.1 | 0.3±0.1 | ||||||
Uric acid (mg/dL) | 7.9±2.1 | 5.0±1.3 | 5.4±1.6 | ||||||
Triglycerides (mg/dL) | 165±10 | 116±7 | - | ||||||
Total cholesterol (mg/dL) | 181±5 | 176±5 | - | ||||||
HDL (mg/dL) | 42±2 | 46±2 | - | ||||||
LDL (mg/dL) | 117±4 | 116±6 | - | ||||||
Hemoglobin (g/dL) | 13.3±0.2 | 12.3±0.2 | 13.9±1.2 | ||||||
Leukocytes (x103/mm3) | 10.0±0.3 | 9.70±0.4 | 6.98±1.37 | ||||||
Neutrophils (x103/mm3) | 6.8±3.3 | 6.7±3.0 | 4.0±1.1 | ||||||
Lymphocytes (x103/mm3) | 2.1±0.8 | 2.1±0.8 | 2.0±0.7 | ||||||
Neutrophil/lymphocyte ratio | 3.7±2.3 | 3.7±2.5 | 1.9± 0.7 | ||||||
Platelets (x103/mm3) | 294.6±107 | 336.4±98.3 | 248.3±61.7 | ||||||
PDW (fL) | 20.7±11.5 | 19.4±8.8 | 15.8±7.2 | ||||||
MPV (fL) | 8.5±1.5 | 8.0±1.0 | 9.8±1.5 | ||||||
SD: Standard deviation; ESR: Erythrocyte sedimentation rate; CRP: C-reactive protein; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; PDW: Platelet distribution width; MPV: Mean platelet volume. |